Drug Shortage Report for GD-CELECOXIB
Report ID | 7589 |
Drug Identification Number | 02291975 |
Brand name | GD-CELECOXIB |
Common or Proper name | GD-CELECOXIB |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-04-28 |
Actual start date | |
Estimated end date | 2017-05-31 |
Actual end date | 2017-06-01 |
Shortage status | Resolved |
Updated date | 2017-06-28 |
Company comments | Resolved June 1, 2017. GD-Celecoxib 200mg will continue to be available GD-Celecoxib 100mg will be available but short dated |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-06-28 | French | Compare |
v4 | 2017-06-28 | English | Compare |
v3 | 2017-04-29 | English | Compare |
v2 | 2017-04-21 | French | Compare |
v1 | 2017-04-21 | English | Compare |
Showing 1 to 5 of 5